{"id":"W2085093059","doi":"10.3747/co.v16i5.510","title":"The Role of Neoadjuvant her2-Targeted Therapies in her2-Overexpressing Breast Cancers","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Santé Montérégie; BC Cancer Agency; Ottawa Hospital; Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec; Sunnybrook Health Science Centre; Hôpital du Saint-Sacrement","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Targeted therapy; Neoadjuvant therapy; Human Epidermal Growth Factor Receptor 2; Adjuvant; Pertuzumab; Internal medicine; Stage (stratigraphy); Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002833032,0.0001824988,0.0006257962,0.0002957481,0.0003256773,0.001084042,0.0003972466,0.000583561,0.001450414],"category_scores_gemma":[0.00351371,0.0001057871,0.0002665533,0.0002679461,0.0009023061,0.0007068012,0.0002624111,0.001054631,0.0002015805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00191473,"about_ca_system_score_gemma":0.003354762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004899367,"about_ca_topic_score_gemma":0.02896939,"domain_scores_codex":[0.9995191,0.0002942373,0.00002762205,0.00002495454,0.00008602434,0.00004808044],"domain_scores_gemma":[0.9986076,0.0007793125,0.0001462463,0.00004085188,0.000238916,0.0001870495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002969819,0.0002089938,0.01597053,0.001585024,0.00008735343,0.001045537,0.0002877586,0.001796515,0.00980436,0.005434525,0.02638902,0.9344205],"study_design_scores_gemma":[0.0008731761,0.004615935,0.09481153,0.004226932,0.0006243094,0.008408448,0.001981141,0.002939321,0.01442695,0.0122422,0.8546855,0.0001644514],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06355885,0.8239031,0.001822854,0.07896673,0.001068384,0.00006342364,0.00009904351,0.00005642699,0.03046106],"genre_scores_gemma":[0.5018357,0.4731283,0.005300289,0.01100188,0.002929041,0.00008486566,0.0001200117,0.0000341222,0.005565812],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004899367,"threshold_uncertainty_score":0.0149827,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06684936890207013,"score_gpt":0.4379933897950619,"score_spread":0.3711440208929918,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}